Compound In Coffee Brewing New Research In Colon, Breast Cancer

Sat, 14 Nov 2009 00:00:00 PST
http://www.medicalnewstoday.com/articles/170904.php

A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Though the studies have not been conducted to determine recommended consumption amounts, scientists say the compound, called trigonelline or "trig," may be a factor in estrogen-dependent breast cancer but beneficial against colon cancer development. "The important thing to get from this is that 'trig' has the ability to act like a hormone," said Dr.

Fertility Preservation Found To Be Safe Option For Breast Cancer Patients

Fri, 13 Nov 2009 03:00:00 PST
http://www.medicalnewstoday.com/articles/170892.php

A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion.

Robotic Repair For Vaginal Prolapse Has Significant Benefits, Mayo Researchers Find

Tue, 10 Nov 2009 06:00:00 PST
http://www.medicalnewstoday.com/articles/170458.php

New Mayo Clinic research has found that robotic surgery for vaginal prolapse (http://www.mayoclinic.org/pelvic-organ-prolapse/) dramatically reduces patient hospital stay and recovery time. These findings are being presented this week at the North Central Section of the American Urological Association in Scottsdale, Ariz.

Early Menopause No Predictor Of Hip Fracture

Tue, 10 Nov 2009 00:00:00 PST
http://www.medicalnewstoday.com/articles/170315.php

Women who have an early menopause are unlikely to have a long term increased risk of hip fractures associated with menopausal bone density weakening, according to a new study from The Australian National University. For decades medical practitioners have understood a link between menopause and a decrease in bone density.

Rates In Risk Factor For Breast Cancer, Atypical Ductal Hyperplasia, Fell In Line With Hormone Therapy Decline, US Study

Mon, 09 Nov 2009 02:00:00 PST
http://www.medicalnewstoday.com/articles/170262.php

Researchers in the US found that the decline in use of postmenopausal hormone therapy may partly explain the fall in incidence of a known risk factor for breast cancer, atypical ductal hyperplasia. They also said their findings support the idea that low and high grade breast cancers develop via different pathways and thereby clarify the role that hormone therapy may play in increasing the rates of breast cancer.

New Key To The Puzzle Of Hormone Therapy And Breast Cancer Uncovered By Scientists

Mon, 09 Nov 2009 02:00:00 PST
http://www.medicalnewstoday.com/articles/170265.php

The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. "Postmenopausal hormone treatment is associated with increased rates of benign breast biopsies, and early and late stages of cancer.

To Provide Stroke Protection, Estrogen Therapy Probably Needs To Be Given Soon After Menopause

Thu, 05 Nov 2009 05:00:00 PST
http://www.medicalnewstoday.com/articles/169964.php

For estrogen replacement to provide stroke protection, it likely must be given soon after levels drop because of menopause or surgical removal of the ovaries, scientists report in the Journal of Neuroscience.

Hormone Replacement Therapy Decreases Mortality In Younger Postmenopausal Woman

Thu, 29 Oct 2009 05:00:00 PST
http://www.medicalnewstoday.com/articles/169161.php

Hormone replacement therapy (HRT) to treat menopausal estrogen deficiency has been in widespread use for over 60 years. Several observational studies over the years showed that HRT use by younger postmenopausal women was associated with a significant reduction in total mortality; available evidence supported the routine use of HRT to increase longevity in postmenopausal women.

Nutri5(R) And Brain Health Related To Treatment Of Menopausal Symptoms

Fri, 23 Oct 2009 02:00:00 PST
http://www.medicalnewstoday.com/articles/168413.php

Earlier this year, the BBC reported that "HRT - Hormone Replacement Therapy - can shrink women's brains"1, after a study was published which showed that brain volume in women taking HRT was smaller in two key areas involved in thinking and memory.

Cutting Breast Cancer Risk And Treating Symptoms Of Menopause With Hormone Mix

Tue, 20 Oct 2009 05:00:00 PST
http://www.medicalnewstoday.com/articles/168017.php

The right combination of estrogen and a selective estrogen receptor modulator (SERM), which blocks the effects of estrogen in breast tissue, could relieve menopause symptoms and cut breast cancer risk, Yale researchers report in an abstract presented at the American Society for Reproductive Medicine (ASRM) scientific meeting in Atlanta, Georgia, October 17-21.

Depomed Reports Results From Two Phase 3 Clinical Trials Evaluating Non-Hormonal Therapy For Menopausal Hot Flashes

Wed, 14 Oct 2009 00:00:00 PST
http://www.medicalnewstoday.com/articles/167205.php

Depomed, Inc. (NASDAQ:DEPO) announced top-line results from the BREEZE 1 and 2 Phase 3 clinical trials evaluating the safety and efficacy of SeradaTM, an investigational non-hormonal extended release formulation of gabapentin for the treatment of menopausal hot flashes. In the higher dose treatment arm of the two doses evaluated, the 1800mg dose achieved positive results at 4 weeks.

Study Looks At Clinical Trial That Tested Estrogen-Plus-Progestin Combination

Tue, 13 Oct 2009 05:00:00 PST
http://www.medicalnewstoday.com/articles/167181.php

Women who developed new-onset breast tenderness after starting estrogen plus progestin hormone replacement therapy were at significantly higher risk for developing breast cancer than women on the combination therapy who didn't experience such tenderness, according to a new UCLA study. The research, published in the Oct.

Clinical Trial Data Documenting Improved Menopause Symptoms

Sat, 10 Oct 2009 00:00:00 PST
http://www.medicalnewstoday.com/articles/166923.php

SE5-OH containing Natural S-equol, a novel soy germ-based ingredient in a supplement, improved menopausal symptoms, including significantly reducing hot flash frequency by nearly 59 percent, according to a peer-reviewed study in Japanese women. This key study was presented in an oral presentation at the North American Menopause Society (NAMS) 20th annual meeting.

Vitamin D Expert Receives Award From North American Menopause Society

Tue, 06 Oct 2009 03:00:00 PST
http://www.medicalnewstoday.com/articles/166448.php

Michael Holick, PhD, MD, director of the Bone Healthcare Clinic and the Vitamin D, Skin and Bone Research Laboratory at Boston University School of Medicine BUSM recently received the 2009 NAMS/Upsher-Smith Laboratories, Inc.Vitamin D Research Award from the North American Menopause Society (NAMS). Holick was presented with the award during NAMS' 20th annual meeting in San Diego, California on September 30 - October 3, 2009. NAMS/Upsher-Smith Laboratories, Inc.

Reducing Breast Cancer Risk By Vigorous Exercise

Thu, 01 Oct 2009 05:00:00 PST
http://www.medicalnewstoday.com/articles/165871.php

Post-menopausal women who engage in moderate to vigorous exercise have a reduced risk of breast cancer. This comes from researchers writing the open access journal BMC Cancer who investigated the link between breast cancer and exercise. "With an estimated 182,460 new cases diagnosed in the United States in 2008, breast cancer is recognized as the most common cancer affecting U.S. women" says Dr. Tricia M Peters from the U.S.

Women Who Are Sexually Satisfied Have Better General Well-Being And More Vitality

Wed, 30 Sep 2009 04:00:00 PST
http://www.medicalnewstoday.com/articles/165705.php

Pre- and post-menopausal women who self-rated themselves as being sexually satisfied had a higher overall psychological well-being score and scores for "positive well-being" and "vitality," compared with sexually dissatisfied women in a study of 295 women sexually active more than twice a month. The study, published in The Journal of Sexual Medicine, also uncovered a positive association between age and well-being, but a negative association for general health.

Hormone Therapy And Mammograms

Tue, 29 Sep 2009 05:00:00 PST
http://www.medicalnewstoday.com/articles/165570.php

Researchers from Boston University School of Medicine (BUSM) are recommending that menopausal women on hormone therapy (HT) continue their treatment prior to having their annual mammogram screenings. These recommendations appear as an editorial in the current on-line issue of Journal of the North American Menopause Society.

Rheumatoid Arthritis And Osteoporosis May Be Reversed By Experimental Approach

Wed, 23 Sep 2009 06:00:00 PST
http://www.medicalnewstoday.com/articles/164931.php

Researchers have identified a mechanism that may keep a well known signaling molecule from eroding bone and inflaming joints, according to an early study published online in the Journal of Clinical Investigation. Bone is continually recycled to maintain its strength through the competing action of osteoclasts, cells that break down aging bone, and osteoblasts, which build new bone.

Long-Term Survival Improved By Switching Early Breast Cancer Patients To Exemestane

Wed, 23 Sep 2009 04:00:00 PST
http://www.medicalnewstoday.com/articles/164908.php

New research has found that switching post-menopausal women with early breast cancer to the drug exemestane (Aromasin) after two or three years of tamoxifen rather than keeping them on tamoxifen for five years improves the chance of remaining cancer free and reduces the risk of death for at least the next six years.

Cost Of Noncompliance Revealed By Study Of Adjuvant Endocrine Treatment For Breast Cancer

Wed, 23 Sep 2009 04:00:00 PST
http://www.medicalnewstoday.com/articles/164910.php

The largest study in the world of treatments for post menopausal, hormone positive breast cancer has shown that patients who continue to take exemestane or tamoxifen do significantly better than patients who start to take one or other drug (or tamoxifen followed exemestane) but then stop.

HRT Linked With Increased Risk Of Lung Cancer, Study Finds

Wed, 23 Sep 2009 03:00:00 PST
http://www.medicalnewstoday.com/articles/164872.php

Women who take hormone replacement therapy are nearly twice as likely to die from lung cancer, according to a study published in the journal Lancet, the Los Angeles Times reports.

Endurance Training Benefits Postmenopausal Women As Much As Younger Women

Mon, 21 Sep 2009 01:00:00 PST
http://www.medicalnewstoday.com/articles/164580.php

Marilyn Graham was 56 when she signed up for a grueling hour of cycling each morning for 12 weeks, occasionally decked out in a mask, a heart monitor and a bag of intravenous fluid and subjected to needle pricks to obtain blood samples. "I was probably the biggest whiner of the group, complaining loudly about the seats and how my butt hurt," said Graham, who writes software for business units on the University of California, Berkeley campus.

Sleep For Women With Hot Flashes Enhanced By Seizure Drug

Wed, 09 Sep 2009 00:00:00 PST
http://www.medicalnewstoday.com/articles/163260.php

Gabapentin, a drug initially used to treat seizures, improves sleep quality in menopausal women with hot flashes, University of Rochester Medical Center researchers report online and in the September issue of the Journal of Women's Health. Approximately 40 percent of menopausal women experience sleep disruption, often in the form of difficulty with sleep initiation and frequent nighttime awakenings.

Estrogen Supplements Not As Effective As Claimed

Fri, 04 Sep 2009 00:00:00 PST
http://www.medicalnewstoday.com/articles/162882.php

Dietary supplements claiming to help postmenopausal women with bone health may not be doing what they say, according to new research from Purdue University. "We found that some plant-derived isoflavones have a modest effect on suppressing bone loss during post-menopause, but more concerning is many dietary supplements that claim to have the power of estrogen do not," said Connie Weaver, distinguished professor of foods and nutrition. "It's buyer beware.

Newer Drug Shows Better Survival Rates Than Tamoxifen For Postmenopausal Breast Cancer Patients

Mon, 24 Aug 2009 00:00:00 PST
http://www.medicalnewstoday.com/articles/161563.php

Postmenopausal women with breast cancer who are treated with the drug letrozole show increased survival rates after surgery compared with those treated with the drug tamoxifen, which is more widely used, according to a study published Thursday in the New England Journal of Medicine,